glp 1 joint inflammation GLP-1 medications may help improve inflammation, but not because they are “anti-inflammatory drugs.” They improve many of the metabolic drivers of chronic inflammation: • Decreasing visceral fat • Improving insulin resistance How Could GLP-1 Agonists Help

Preclinical and in vitro literature can help define the boundaries of a research question

Exendin-4 has been shown to reduce advanced glycation end product (AGE)-induced interleukin (IL)-6 and TNF- production, the expression of receptor for AGE (RAGE), and cell death in mesangial cells (Wang et al., 2014)

AstraZeneca PLC is a biopharmaceutical company that researches, develops, manufactures, and sells prescription drugs

The company says it aims to get its patients to a place where they no longer have to use GLP-1s to manage their weight

Off-label prescribing can also trigger concerns around fraud, waste, and abuse, particularly in regulated markets

Using WT mouse caSMCs, brief, 10-minute incubations with GLP-1(2836) caused concentration-dependent increases in ATP (Figure 4A)